OncoCyte (OCX) Announces Proposed $25M Registered Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. NDAQ

Go back to OncoCyte (OCX) Announces Proposed $25M Registered Offering

Oncocyte Announces $25 Million Registered Offering

January 20, 2021 4:08 PM EST

Offering Led by Current Shareholder and Healthcare Investor, Pura Vida Investments, Substantially Increasing Its Holdings

Further Strengthens Balance Sheet to Support Ongoing Commercial and Development Activities across Cancer Care Continuum

IRVINE, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it has entered into definitive agreements with its two largest institutional investors to purchase approximately $25 million of... More